Update in glaucoma: the new pharmacotherapies. Brimonidine versus apraclonidine.
Crichton
A C
AC
D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D000068438:Brimonidine Tartrate; D003000:Clonidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D011810:Quinoxalines / Q000008:administration & dosage* / Q000009:adverse effects
D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D011810:Quinoxalines; D000068438:Brimonidine Tartrate; C016986:apraclonidine; D003000:Clonidine